Growing community of inventors

Story City, IA, United States of America

John Rathmacher

Average Co-Inventor Count = 3.52

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 38

John RathmacherShawn Baier (17 patents)John RathmacherNaji N Abumrad (13 patents)John RathmacherJohn Fuller, Jr (9 patents)John RathmacherSteve Nissen (9 patents)John RathmacherLarry Kolb (4 patents)John RathmacherNaji Abumrad (3 patents)John RathmacherJohn Fuller (3 patents)John RathmacherMartin Purpura (2 patents)John RathmacherMatthew Legge (2 patents)John RathmacherLisa Pitchford (2 patents)John RathmacherJay Hoffman (1 patent)John RathmacherCharles Flynn (1 patent)John RathmacherJoceylyn Seda (1 patent)John RathmacherSteven Nissen (1 patent)John RathmacherSteven Nissen (0 patent)John RathmacherJohn Rathmacher (21 patents)Shawn BaierShawn Baier (19 patents)Naji N AbumradNaji N Abumrad (16 patents)John Fuller, JrJohn Fuller, Jr (10 patents)Steve NissenSteve Nissen (9 patents)Larry KolbLarry Kolb (4 patents)Naji AbumradNaji Abumrad (5 patents)John FullerJohn Fuller (6 patents)Martin PurpuraMartin Purpura (8 patents)Matthew LeggeMatthew Legge (2 patents)Lisa PitchfordLisa Pitchford (2 patents)Jay HoffmanJay Hoffman (1 patent)Charles FlynnCharles Flynn (1 patent)Joceylyn SedaJoceylyn Seda (1 patent)Steven NissenSteven Nissen (3 patents)Steven NissenSteven Nissen (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Metabolic Technologies, Inc. (17 from 19 patents)

2. Tsi Group Co., Ltd. (2 from 4 patents)

3. Mti Biotech, Inc. (1 from 2 patents)

4. Metaolic Technologies, LLC (1 from 1 patent)


21 patents:

1. 12383515 - Compositions and methods of use of γ-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver

2. 12370159 - Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics

3. 12251393 - Compositions containing adenosine triphosphate (ATP) and methods of use

4. 12220391 - Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy

5. 12161654 - Stability of vitamin D in β-hydroxy-β-methylbutyrate (HMB)

6. 11666593 - Compositions containing adenosine triphosphate (ATP) and methods of use

7. 11547713 - Nutritional intervention for improving muscular function and strength

8. 11406609 - Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy

9. 11173167 - Nutritional intervention for improving muscular function and strength

10. 10925845 - Stability of vitamin D in β-hydroxy-β-methylbutyrate (HMB)

11. 10888576 - Composition of HMB and ATP and methods of use

12. 10772856 - Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for decreasing fat mass

13. 10682363 - Nutritional intervention for improving muscular function and strength

14. 10213399 - Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy

15. 10201551 - Nutritional intervention for improving muscular function and strength

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/14/2026
Loading…